Correlation Between Pyxis Oncology and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both Pyxis Oncology and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pyxis Oncology and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pyxis Oncology and Revelation Biosciences, you can compare the effects of market volatilities on Pyxis Oncology and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pyxis Oncology with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pyxis Oncology and Revelation Biosciences.
Diversification Opportunities for Pyxis Oncology and Revelation Biosciences
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Pyxis and Revelation is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Pyxis Oncology and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Pyxis Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pyxis Oncology are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Pyxis Oncology i.e., Pyxis Oncology and Revelation Biosciences go up and down completely randomly.
Pair Corralation between Pyxis Oncology and Revelation Biosciences
Given the investment horizon of 90 days Pyxis Oncology is expected to under-perform the Revelation Biosciences. In addition to that, Pyxis Oncology is 1.57 times more volatile than Revelation Biosciences. It trades about -0.14 of its total potential returns per unit of risk. Revelation Biosciences is currently generating about -0.03 per unit of volatility. If you would invest 85.00 in Revelation Biosciences on August 30, 2024 and sell it today you would lose (9.50) from holding Revelation Biosciences or give up 11.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pyxis Oncology vs. Revelation Biosciences
Performance |
| Timeline |
| Pyxis Oncology |
| Revelation Biosciences |
Pyxis Oncology and Revelation Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pyxis Oncology and Revelation Biosciences
The main advantage of trading using opposite Pyxis Oncology and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pyxis Oncology position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.| Pyxis Oncology vs. Zura Bio Limited | Pyxis Oncology vs. Altamira Therapeutics | Pyxis Oncology vs. Elevation Oncology | Pyxis Oncology vs. Mereo BioPharma Group |
| Revelation Biosciences vs. Bright Minds Biosciences | Revelation Biosciences vs. HP Inc | Revelation Biosciences vs. Intel | Revelation Biosciences vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |